Scientists investigate immune cell defects in rare blood vessel disease
NCT ID NCT02857192
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at blood samples from 41 people with giant cell arteritis (Horton's disease), a condition that causes inflammation in blood vessels. Researchers examined specific immune cells called regulatory T cells to see if they are defective in this disease. The goal is to better understand the disease and potentially find new treatment targets.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward new, more targeted treatments for giant cell arteritis by understanding how immune cells work.
- What could go wrong
- This is a small, early-stage study focused on understanding the disease, not testing a treatment. The findings may not lead directly to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HORTON'S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Universitaire
Dijon, 21079, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.